- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IMMU-132
Total 3803 results
-
Gilead SciencesApproved for marketingMetastatic Triple-Negative Breast Carcinoma
-
Gilead SciencesActive, not recruitingMetastatic Solid TumorUnited States, Spain, France, Hong Kong, Australia, Belgium, Taiwan, Canada
-
Gilead SciencesRecruitingLiver Failure | Advanced or Metastatic Solid TumorFrance, United States
-
Gilead SciencesRecruiting
-
Gilead SciencesParexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions...Active, not recruitingMetastatic Triple-negative Breast CancerChina
-
Gilead SciencesRecruitingAdvanced Solid TumorsUnited States
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Gilead SciencesCompletedCervical Cancer | Urinary Bladder Neoplasms | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Cancer | Esophageal Cancer | Ovarian Epithelial Cancer | Glioblastoma Multiforme | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Renal Cell Cancer and other conditionsUnited States
-
Gilead SciencesWithdrawnTriple-negative Breast Cancer
-
Gilead SciencesEnrolling by invitationMetastatic Solid TumorFrance, United States, Belgium
-
Gilead SciencesCompletedMetastatic Colorectal CancerUnited States
-
Yale UniversityGilead SciencesRecruitingOvarian CarcinomaUnited States
-
Gilead SciencesTerminatedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
Yale UniversityGilead SciencesRecruitingEndometrial CarcinomaUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Gilead SciencesRecruiting
-
Gilead SciencesActive, not recruitingNon-Small Cell Lung CancerUnited States, Belgium, Spain, United Kingdom, Australia, Japan, Italy, France, Israel, Netherlands, Puerto Rico, Portugal, Greece, Brazil, Poland, Canada, Austria, Germany, Mexico, Turkey
-
Gilead SciencesCompletedChronic Lymphocytic LymphomaUnited States
-
G1 Therapeutics, Inc.Active, not recruitingTriple Negative Breast CancerUnited States
-
Gilead SciencesTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-hodgkin's Lymphoma | Small Lymphocytic LymphomaUnited States
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Gilead SciencesCompletedPancreatic CancerUnited States
-
PfizerCompletedEncephalitis, Tick-BorneAustria, Germany, Poland
-
Gilead SciencesAlliance Foundation Trials, LLC.Recruiting
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Stand Up To CancerActive, not recruitingBreast Cancer | Triple Negative Breast Cancer | Circulating Tumor DNA | Residual CancerUnited States
-
Gilead SciencesCompletedMultiple Myeloma | Myeloma, Plasma-Cell | PLASMACYTOMAUnited States
-
MediBeaconCompleted
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
M.D. Anderson Cancer CenterGilead SciencesRecruiting
-
pharmaand GmbHGilead SciencesTerminatedOvarian Cancer | Solid Tumor | Urothelial Carcinoma | Triple-negative Breast CancerUnited States
-
University of PennsylvaniaHopeLab FoundationCompleted
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
SRH Gesundheitszentrum Bad HerrenalbRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Elisabethinen HospitalBaxter Healthcare Corporation; ASOKLIFUnknownTick Borne EncephalitisAustria, Czech Republic
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Dana-Farber Cancer InstituteGilead Sciences; AstraZeneca; Daiichi Sankyo, Inc.; Eisai Inc.; Paxman Coolers LimitedRecruiting
-
Gilead SciencesCompletedNon-Hodgkin's Lymphoma | Lymphoma, Diffuse | Lymphoma, Diffuse, Mixed Lymphocytic-HistiocyticFrance, United Kingdom
-
Gilead SciencesTerminatedPurpura, Thrombocytopenic, Idiopathic | Autoimmune Thrombocytopenic Purpura | Purpura, Thrombocytopenic, AutoimmuneUnited States
-
Tianjin Chasesun Pharmaceutical Co., LTDEnrolling by invitation
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
Changchun Intellicrown Pharmaceutical Co. LTDRecruitingNonalcoholic Steatohepatitis (NASH)China
-
PfizerCompletedTick-borne EncephalitisAustria, Germany, Poland
-
Immunic AGTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom
-
Dr. Stéphanie DelstancheSYSNAV; Centre Hospitalier Universitaire de LiegeCompletedMultiple SclerosisBelgium
-
Gilead SciencesCompletedLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Low-Grade | Lymphoma, Small Lymphocytic | Leukemia, Prolymphocytic | NHL | CLL | Leukemia, Lymphocytic, Chronic | Lymphoma, Intermediate-Grade | Lymphoma, Large-Cell | Lymphoma, Mixed-Cell | Lymphoma, Small-Cell | Leukemia, B-Cell, Chronic | Leukemia... and other conditionsUnited States